Acquisitions & Agreements
Acquisitions & Agreements
• Agile Software (San Jose, CA) has formed a development partnership with Versal Technologies (Boston) to create new versions of Agile’s Validation Protocol Pak. The Pak allows medical device manufacturers using the Agile software products to validate their change processes as compliant with current FDA good manufacturing practices.
• Coram Healthcare (Denver) will take Coram Prescription Services and its nearly $80 million mail order and pharmacy benefit management division online later this year. The company will use Mediaconsult.com Inc. (Bermuda) to provide content and promotion for the new site. Coram will be the exclusive prescription and over-the-counter product provider to Mediconsult.com’s visitor base.
• FCG International (Yardley, PA) has been acquired by Healthway Communications International (Austin, TX). FCG develops publication programs, symposia, speakers’ bureaus, and accredited continuing education programs for nurses, nurse practitioners, physician assistants, pharmacists, and physicians.
• GE Medical Systems (Milwaukee, Wisconsin) has acquired Applicare Medical Imaging (Zeist, the Netherlands), a privately-held developer of systems that archive and transmit electronic medical images and information. Financial terms of the transaction were not released. Applicare designs and produces a range of PC/NT-based systems for picture archiving (PACS) and teleradiology. PACS allow medical providers to electronically archive, display, and transmit images created by ultrasound, magnetic resonance, computed tomography, X-ray, and other imaging devices throughout a networked health care system. GE Medical said it will fulfill an Applicare contract to supply components to IBM as part of a major PACS project with the U.S. government. And Applicare will continue to supply PACS components through its existing OEM channels. Applicare’s existing management team will join GE, and its headquarters operations will remain in Zeist.
• IMS Health’s Enrisco Managed Care Technologies unit (London) and Cognizant Technology Solutions (West Teaneck, NJ), have formed an alliance to develop products and services for information technology in managed care organizations. The goal is to enable managed care organizations to deploy software and technology quickly and economically, with grater flexibility and interoperability.
• Lifetime Online (New York), a source of information for women, and InteliHealth (Blue Bell, PA), an online consumer information source, have agreed to share health content and develop new applications relating to women. The new information sources will have features such as Lifetime Online’s "Breast Cancer Update," which will include a chat forum and library of information, and InteliHealth’s "Ask the Doc" area.
• Molecular Applications Group (Palo Alto, CA) has completed development of its Stingray Expression Analysis System. The tool will allow researchers using products from Affymetrix (Santa Clara, CA) to broaden their scientific reach with access to gene sequence and function information, helping to identify and select drug targets.
• Molecular Simulations (San Diego) products have been selected for use by Cytoclonal Pharmaceutics (Dallas). The company will install its Catalyst, Cerius2, and Insight II products for Cytoclonal’s rational drug design efforts to improve diagnostics and therapeutics for cancer and infectious diseases, such as HIV.
• Paradigm Genetics (Research Triangle Park, NC) and PE Biosystems (Foster City, CA) have signed a research agreement to develop bioinformatics software for functional genomics. The collaboration is intended to allow the organization of databases and analysis of function data associated with gene sequences. The goal is to develop a scaffold and query tools for organizing accessing, and analyzing large amounts of information associated with gene sequence.
• PE Corporation (Norwalk, Connecticut) has completed the sale of its Analytical Instruments Division to EG&G (Wellesley, Massachusetts), the value of the deal approximately $425 million. PE said it sold the division in order to concentrate on enhancing its position as a supplier of products, services, and information in the life sciences. As part of the deal, the rights to the Perkin-Elmer brand name were transferred to EG&G. PE shareholders approved a recapitalization proposal that was previously announced in which the company was reorganized as PE Corporation, and two new common stocks were issued: PE Biosystems Group and Celera Genomics Group. PE Corporation currently comprises two operating groups. PE Biosystems Group develops and markets instrument-based systems, reagents, software, and contract-related services to the life science industry and research community. Celera Genomics Group intends to become the definitive source of genomic and related medical information.
• SGI (Mountain View, CA) has signed an agreement with the National Aeronautics and Space Admin istration (Washington) to collaborate on advanced supercomputer technology development. The agreement provides for a wide range of information technology uses, such as computational modeling for astrobiology and virtual surgery for long-duration space missions.
• Systems Consulting Co. (Portland, ME) and Clarkston-Potomac (Durham, NC) have formed a development partnership to deliver CARS/ERP Xchange, a standard interface. It will facilitate the exchange of critical contract management information between Clarkston-Potomac’s SAP National Implementation Partner enterprise backbone, and Systems Consulting’s flagship CARS/IS solution.
• VIDAR Systems (Herndon, VA) has signed a value-added reseller agreement with META Solutions (Linthicum, MD). META will include VIDAR products in its products for teleradiology and PACS.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.